Xinjiang Tianshan Animal Husbandry Bio-engineering Co., Ltd. (SHE:300313)
China · Delayed Price · Currency is CNY 9.40
+0.14 (1.51%)
May 28, 2026, 3:04 PM CST
SHE:300313 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Revenue | 288.54 | 194.62 | 132.52 | 133.43 | 72.08 | 105.38 |
Other Revenue | 5.67 | 5.67 | 5.08 | 4.07 | 4.27 | 2.6 |
| 294.21 | 200.29 | 137.6 | 137.5 | 76.35 | 107.98 | |
Revenue Growth (YoY) | 103.31% | 45.55% | 0.07% | 80.09% | -29.29% | -33.88% |
Cost of Revenue | 276.8 | 191.75 | 155.7 | 122.12 | 67.06 | 105.06 |
Gross Profit | 17.41 | 8.54 | -18.1 | 15.38 | 9.29 | 2.92 |
Selling, General & Admin | 26.41 | 26.08 | 26.96 | 26.18 | 18.6 | 24.74 |
Research & Development | 0.9 | 0.97 | 1.16 | 1.51 | 0.51 | 1.5 |
Other Operating Expenses | 2.58 | 0.44 | 0.11 | 0.05 | 0.08 | 0.58 |
Operating Expenses | 33.6 | 31.04 | 28.85 | 28.73 | 18.25 | 29.05 |
Operating Income | -16.19 | -22.5 | -46.95 | -13.35 | -8.96 | -26.13 |
Interest Expense | -8.13 | -9.27 | -10.74 | -10.98 | -14.1 | -14.53 |
Interest & Investment Income | 3.44 | 3.46 | 3.47 | 3.24 | 0.25 | 1.37 |
Currency Exchange Gain (Loss) | - | - | - | 0 | 0.11 | -0.03 |
Other Non Operating Income (Expenses) | -0.32 | -0.31 | -0.12 | -0.7 | 0.26 | -2.34 |
EBT Excluding Unusual Items | -20.61 | -28.61 | -54.33 | -21.79 | -22.45 | -41.65 |
Gain (Loss) on Sale of Investments | - | - | - | - | -8.05 | - |
Gain (Loss) on Sale of Assets | 0.09 | 0.01 | -0.18 | -1.21 | -0.05 | 42.7 |
Asset Writedown | -0.83 | -1.07 | -10.64 | -0 | -0.82 | -33.48 |
Legal Settlements | - | - | -1.54 | -1.92 | -1.7 | - |
Other Unusual Items | 9.16 | 7.71 | 3.29 | 5.61 | 2.6 | 3.89 |
Pretax Income | -12.2 | -21.96 | -63.4 | -19.31 | -30.47 | -28.55 |
Income Tax Expense | 4.37 | 4.23 | 3.68 | 2.78 | 1.56 | 1.85 |
Earnings From Continuing Operations | -16.57 | -26.19 | -67.08 | -22.08 | -32.03 | -30.39 |
Minority Interest in Earnings | -1.5 | -1 | 1.13 | 0.08 | 0.2 | 3.09 |
Net Income | -18.06 | -27.19 | -65.95 | -22 | -31.83 | -27.3 |
Net Income to Common | -18.06 | -27.19 | -65.95 | -22 | -31.83 | -27.3 |
Shares Outstanding (Basic) | 289 | 307 | 313 | 314 | 318 | 303 |
Shares Outstanding (Diluted) | 289 | 307 | 313 | 314 | 318 | 303 |
Shares Change (YoY) | -7.86% | -1.86% | -0.42% | -1.26% | 4.93% | -3.07% |
EPS (Basic) | -0.06 | -0.09 | -0.21 | -0.07 | -0.10 | -0.09 |
EPS (Diluted) | -0.06 | -0.09 | -0.21 | -0.07 | -0.10 | -0.09 |
Free Cash Flow | -13.99 | -4.24 | 11.67 | -15.39 | -9.22 | -37.15 |
Free Cash Flow Per Share | -0.05 | -0.01 | 0.04 | -0.05 | -0.03 | -0.12 |
Gross Margin | 5.92% | 4.26% | -13.15% | 11.19% | 12.17% | 2.70% |
Operating Margin | -5.50% | -11.23% | -34.12% | -9.71% | -11.73% | -24.20% |
Profit Margin | -6.14% | -13.57% | -47.93% | -16.00% | -41.69% | -25.29% |
Free Cash Flow Margin | -4.76% | -2.11% | 8.48% | -11.20% | -12.07% | -34.40% |
EBITDA | -4.15 | -10.4 | -34.63 | -0.34 | 4.33 | -12.2 |
EBITDA Margin | -1.41% | -5.19% | -25.17% | -0.24% | 5.67% | -11.29% |
D&A For EBITDA | 12.05 | 12.1 | 12.31 | 13.01 | 13.29 | 13.93 |
EBIT | -16.19 | -22.5 | -46.95 | -13.35 | -8.96 | -26.13 |
EBIT Margin | -5.50% | -11.23% | -34.12% | -9.71% | -11.73% | -24.20% |
Revenue as Reported | 294.21 | 200.29 | 137.6 | 137.5 | 76.35 | 107.98 |
Advertising Expenses | - | 0.03 | 1.27 | 0.29 | 0.04 | 0.03 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.